Cargando…
Acute oxalate nephropathy associated with orlistat
Background: Obesity is a major world-wide epidemic which has led to a surge of various weight loss-inducing medical or surgical treatments. Orlistat is a gastrointestinal lipase inhibitor used as an adjunct treatment of obesity and type 2 diabetes mellitus to induce clinically significant weight los...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Society of Diabetic Nephropathy Prevention
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844913/ https://www.ncbi.nlm.nih.gov/pubmed/27152294 http://dx.doi.org/10.15171/jnp.2016.14 |